- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01504152
International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center
July 11, 2013 updated by: Memorial Sloan Kettering Cancer Center
Survey to Assess International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center
The purpose of this study is to survey patients who underwent hematopoietic stem cell transplant (HSCT) to assess if they have traveled or not internationally after transplant.
This information will help to improve the understanding of the needs for travel health strategies and interventions to provide healthy and safe travel to HSCT patients.
The findings of this survey will also be used to develop travel health related interventions for patients living with cancer as well.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
519
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10065
- Memorial Sloan-Kettering Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who received HSCT at MSKCC between 2005-2010 and were alive after the first year after HSCT.
Description
Inclusion Criteria:
- Hematopoietic Stem Cell Transplant (HSCT) recipients at MSKCC from 1/1/2005 to 12/31/2010.
- Age at HSCT ≥ 18 years
- Permanent mailing address in the United States of America
Exclusion Criteria:
- Subject unable to fill the questionnaire due to language barriers.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
patients who received HSCT at MSKCC between 2005-2010
A self-administered patient questionnaire will be used to collect data that will assess the prevalence of international travel after HSCT and travel related morbidity and exposure risks among HSCT recipients.
|
The intervention is a self-administered questionnaire that is voluntarily completed by the subject.
This questionnaire has been previously validated and demonstrated to be reproducible in English speaking travelers.
The final version of the survey questionnaire consists of 49 questions.Patients who never traveled after HSCT will answer only eighteen questions related to their medical and HSCT history in addition to their demographics.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
prevalence of international travel
Time Frame: 2 years
|
of the targeted patients Proportion of Hematopoietic Stem Cell Transplant (HSCT) patients who traveled internationally within two years after HSCT
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
international travel was during a high-risk specific period
Time Frame: 2 years
|
Proportion of patients traveling to destinations that are at high risk areas for infections
|
2 years
|
patients that sought pre-travel health advice
Time Frame: 2 years
|
among those who traveled to high risk areas for infections
|
2 years
|
travelers that becomes ill and required medical attention
Time Frame: 2 years
|
during or after return from international travel.
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Monika Shah, MD, Memorial Sloan Kettering Cancer Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2011
Primary Completion (Actual)
July 1, 2013
Study Completion (Actual)
July 1, 2013
Study Registration Dates
First Submitted
January 3, 2012
First Submitted That Met QC Criteria
January 4, 2012
First Posted (Estimate)
January 5, 2012
Study Record Updates
Last Update Posted (Estimate)
July 12, 2013
Last Update Submitted That Met QC Criteria
July 11, 2013
Last Verified
July 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- 11-176
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hematopoietic Stem Cell Transplant
-
Brigham and Women's HospitalDana-Farber Cancer Institute; Duke University; H. Lee Moffitt Cancer Center and...Not yet recruitingHematopoietic Stem Cell TransplantUnited States
-
Children's Hospital Medical Center, CincinnatiRecruitingHematopoietic Stem Cell TransplantUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedHematopoietic Stem Cell TransplantUnited States
-
University of Michigan Rogel Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...RecruitingHematopoietic Stem Cell TransplantUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedHematopoietic Stem Cell TransplantUnited States
-
Children's Hospital Los AngelesCompleted
-
Case Comprehensive Cancer CenterCompletedHematopoietic Stem Cell TransplantUnited States
-
Assistance Publique - Hôpitaux de ParisUnknownHematopoietic Stem Cell TransplantFrance
-
Children's Hospital Medical Center, CincinnatiCompletedHematopoietic Stem Cell TransplantUnited States
-
University of California, San FranciscoCompletedHematopoietic Stem Cell TransplantUnited States
Clinical Trials on questionnaire
-
H. Lee Moffitt Cancer Center and Research InstituteSan Diego State University; University of Minnesota; University of ArizonaCompletedAnxiety | Psychological StressUnited States
-
Centre Hospitalier Universitaire de NiceCompletedGeneral Population | TDAH | Children Aged 5 to 18 YearsFrance
-
Imperial College LondonRoyal Marsden NHS Foundation Trust; University College London Hospitals; The... and other collaboratorsCompleted
-
Minneapolis Veterans Affairs Medical CenterUnited States Department of DefenseCompletedLower Limb Amputation Below Knee (Injury) | Lower Limb Amputation Above Knee (Injury)United States
-
NSABP Foundation IncNational Cancer Institute (NCI)Completed
-
Rabin Medical CenterCompleted
-
Stanford UniversityRecruitingAstigmatism | Nearsightedness | FarsightednessUnited States
-
University of LiegeCompletedCritical Illness | Covid19 | Psychological Stress | FamilyBelgium
-
Imperial College Healthcare NHS TrustNot yet recruitingCervical Myelopathy
-
National Taiwan University HospitalNational Taiwan UniversityUnknownComputerized Physician Order EntryTaiwan